DXT — Dexterra Income Statement
0.000.00%
- CA$628.64m
- CA$740.36m
- CA$1.00bn
- 84
- 81
- 64
- 91
Annual income statement for Dexterra, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 471 | 733 | 972 | 928 | 1,003 | 
| Cost of Revenue | |||||
| Gross Profit | 60 | 102 | 103 | 141 | 160 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 391 | 697 | 961 | 869 | 936 | 
| Operating Profit | 80.6 | 36 | 10.1 | 59 | 67.1 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 76.7 | 33.3 | 3.22 | 47.5 | 53.6 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 64.5 | 24.6 | 3.71 | 35.8 | 37.5 | 
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 64 | 24.4 | 3.43 | 26.6 | 19.9 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 64 | 24.4 | 3.43 | 26.6 | 19.9 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.119 | 0.286 | 0.199 | 0.655 | 0.58 | 
| Dividends per Share |